News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Conference News AHA 2021 Racial/Ethnic Disparities in AF Care Persist Despite Dual VA, Medicare Coverage Todd Neale November 19, 2021
News Conference News AHA 2021 Avoiding AF Triggers Doesn’t Improve Quality of Life: I-STOP-AFib Michael O'Riordan November 14, 2021
News Conference News AHA 2021 Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders L.A. McKeown November 14, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News EACTS 2021 More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients Michael O'Riordan October 18, 2021
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Features When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles Todd Neale September 28, 2021
News Daily News FDA Investigating Possible Sex Differences in LAAO Outcomes Todd Neale September 27, 2021
News Conference News HFSA 2021 PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF Todd Neale September 13, 2021
News Conference News ESC 2021 STEP Trial Supports Lower BP Goal in Older Patients With Hypertension Todd Neale August 30, 2021
News Conference News ESC 2021 Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’ L.A. McKeown August 28, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021